- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Inhibition of Leukotriene Production by N-(4-(4-(Diphenylmethyl)-1-piperazinyl)butyl)-3-(6-methyl-3-pyridyl) Acrylamide (AL-3264), a New Antiallergic Agent.
-
- Ishii Katsumi
- Department of Pharmacology, Exploratory Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
- Yakuo Ikuhisa
- Department of Pharmacology, Exploratory Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
- Motoyoshi Satoru
- Department of Pharmacology, Exploratory Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
- Nakagawa Hiroyo
- Drug Regulatory Affairs, Dainippon Pharmaceutical Co., Ltd.
-
- Nakamura Hideo
- Department of Toxicology, Exploratory Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
Search this article
Description
The effects of AL-3264, which exhibits a 5-lipoxygenase (5-LO) inhibiting property by blocking histamine H1-receptors and inhibition of histamine release, were examined on leukotriene (LT) production and LT-mediated responses. AL-3264 (1-30 μM) inhibited the A23, 187-induced LT production from human leukocytes with almost the same potency as that of nordihydroguaiaretic acid. AL-3264 (30-100 mg/kg, p.o.) inhibited the antigen-induced LT production in the abdominal cavity of passively sensitized rats; its effect was as potent as that of AA-861, a 5-LO inhibitor. AL-3264 (30 μM) suppressed both the initial and sustained phases of the antigen-induced contractions in isolated trachea from actively sensitized guinea pig. Phenidone (3 μM), a dual inhibitor of 5-LO and cyclooxygenase (CO), suppressed the sustained phase, while indomethacin was without effect on either phase. AL-3264 (40-160 mg/kg, p.o.) suppressed the arachidonic acid-induced ear edema in mice, for which 5-LO inhibitors were effective but antihistamines were not. The anti-edematous effect of AL-3264 (160 mg/kg) was reduced by intradermal administration of LTC4 (0.1 μg). These results suggest that AL-3264 suppresses LT production in vivo and in vitro by inhibiting 5-LO activity, and this property may contribute to the antiallergic effect of AL-3264.
Journal
-
- The Japanese Journal of Pharmacology
-
The Japanese Journal of Pharmacology 65 (1), 19-25, 1994
The Japanese Pharmacological Society
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679261246976
-
- NII Article ID
- 130000840554
-
- NII Book ID
- AA00691188
-
- COI
- 1:CAS:528:DyaK2cXkt1Knu70%3D
-
- ISSN
- 13473506
- 00215198
-
- PubMed
- 7916384
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed